John Hunter Hospital, Newcastle
Gastroenterology
Dr. Nicholas J. Talley, MD
|
|
Give Review
Nicholas J. Talley practices Gastroenterology. He received 3 awards: "Fellow", "Fellow (AGAF)" and "Whos Who in Medicine and Healthcare". Nicholas Talley is a published doctor. He has 100 publications published. The most current publication "Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders."
Publications
- Evidence Against Routine Testing of Patients With Functional Gastrointestinal Disorders for Celiac Disease: A Population-based Study.
- Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders.
- Family history of mental illness or alcohol abuse and the irritable bowel syndrome.
- Letter: role of GNβ3 polymorphisms in oesophageal adenocarcinoma and gastroesophageal reflux disease.
- Dyspepsia in the community: value of a community-based mailed survey to identify potential participants for a randomized clinical trial.
- Effects of Birth Cohorts on the Irritable Bowel Syndrome Support Early-Life Risk Factors.
- Lack of Familial Aggregation in Chronic Constipation Excluding Irritable Bowel Syndrome: A Population-Based Study.
- Prevalence and risk factors for dysphagia: a USA community study.
- Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia.
- The Diagnosis of Esophageal Eosinophilia is Not Increased in the Summer Months.
- Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome.
- Prevalence and risk of developing comorbid conditions in patients with chronic constipation.
- Anxiety disorders and risk of self-reported ulcer: a 10-year longitudinal study among US adults.
- Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community.
- A case-control study of childhood trauma in the development of irritable bowel syndrome.
- Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation.
- Loss-of-function of the Voltage-gated Sodium Channel NaV1.5 (Channelopathies) in Patients with Irritable Bowel Syndrome.
- The effects of ageing on the onset and disappearance of unexplained abdominal pain: a population-based study.
- Letter: PPI-responsive oesophageal eosinophilia - from initial skepticism to consistent prospective data; authors' reply.
- The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.
- Acid and non-acid reflux in patients refractory to proton pump inhibitor therapy: is gastroparesis a factor?
- An update on current pharmacotherapy options for dyspepsia.
- Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placeb...
- Letter: East-West differences in the economic impact of functional dyspepsia - authors' reply.
- Functional dyspepsia: the economic impact to patients.
- Report from the multinational irritable bowel syndrome initiative 2012.
- A link between physician-diagnosed ulcer and anxiety disorders among adults.
- Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study.
- Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight.
- Associations between medication use and functional gastrointestinal disorders: a population-based study.
- Endoscopic full-thickness biopsy of the gastric wall with defect closure by using an endoscopic suturing device: survival porcine study.
- Dietary modification as a treatment for irritable bowel syndrome.
- Risk of Gastroparesis in Subjects With Type 1 and 2 Diabetes in the General Population.
- Response to yang et Al.
- Response to atreja et Al.
- Reply to akobeng.
- Erosive Esophagitis Is a Risk Factor for Barrett's Esophagus: A Community-Based Endoscopic Follow-Up Study.
- Bugs, Stool, and the Irritable Bowel Syndrome: Too Much Is as Bad as Too Little?
- Clinical value of duodenal biopsies - Beyond the diagnosis of coeliac disease.
- What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? : Are current IBS symptom threshold...
- Increased Incidence of Eosinophilic Esophagitis in Children and Adults With Celiac Disease.
- Excess Comorbidity Prevalence and Cost Associated with Functional Dyspepsia in an Employed Population.
- ACP journal club. Quadruple-drug therapy was better than triple-drug therapy for eradicating Helicobacter pylori in adults.
- The Role of Eosinophils and Mast Cells in Intestinal Functional Disease.
- Corrigendum: antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
- Prospective diary evaluation of unexplained abdominal pain and bowel dysfunction: a population-based colonoscopy study.
- Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study.
- ACP Journal Club. Rifaximin relieved global symptoms and bloating in the irritable bowel syndrome without constipation.
- Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett's Esophagus: A Population-Based Study.
- Health Insurance Portability and Accountability Act (HIPAA) authorization and survey nonresponse bias.
- Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
- Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
- Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
- Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
- Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
- Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
- 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.
- Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.
- Screening for Celiac Disease in a North American Population: Sequential Serology and Gastrointestinal Symptoms.
- Low Grade Esophageal Eosinophilia in Adults: An Unrecognized Part of the Spectrum of Eosinophilic Esophagitis?
- Rumination syndrome.
- Small Bowel Homing T Cells Are Associated With Symptoms and Delayed Gastric Emptying in Functional Dyspepsia.
- Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea.
- Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study.
- Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis.
- Functional dyspepsia: time to change clinical trial design?
- An update on irritable bowel syndrome: from diagnosis to emerging therapies.
- Irritable bowel syndrome and chronic pelvic pain: a population-based study.
- The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease.
- A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type.
- Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study.
- Internet option in a mail survey: more harm than good?
- The use of digital rectal examinations in palliative care inpatients.
- Functional dyspepsia impacts absenteeism and direct and indirect costs.
- Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue.
- Impact of functional gastrointestinal disorders on survival in the community.
- Patients dismissed from the hospital with a diagnosis of noncardiac chest pain: cardiac outcomes and health care utilization.
- Familial aggregation of irritable bowel syndrome: a family case-control study.
- Gastroduodenal disorders.
- Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study.
- Onset and risk factors for fecal incontinence in a US community.
- Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis.
- Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome.
- The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice.
- A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
- Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.
- Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report.
- Editorial: At last, time for the next transformation.
- So you aspire to be a Professor?
- Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions.
- Pathogenesis of irritable bowel syndrome are genes a SERT-ainty?
- AJG series: molecular biology for clinicians.
- Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota.
- Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
- Gastroenterology in the elderly. Preface.
- Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study.
- Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule.
- Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia.
- Minimum clinically important difference for the Nepean Dyspepsia Index, a validated quality of life scale for functional dyspepsia.
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Fellow
- Fellow (AGAF)
- Whos Who in Medicine and Healthcare
Education
-
Mayo School of Graduate Medical Education -
University of New South Wales Faculty of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Similar Doctors
|
|
Dr. Kyle P. Etzkorn, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Paul A. Sievert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Buffie M. Reid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gaurang N. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nassim Y. El Hajj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen M. Lange, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dawn D. Francis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Surakit Pungpapong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria L. Yataco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele A. Carter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime Aranda-Michel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bharat K. Misra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda A. Diteodoro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann J. Lee, MD |
|
|
Dr. Seyed Reza Abbaszadeh Hejazi, MD
This Doctor is OpenDoctor Recommended.
|